e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Novel therapies for asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Montelukast and frequency of exacerbations of asthma
W. A. Biernacki, S. A. Kharitonov, H. M. Biernacka, P. J. Barnes (London, Gravesend, United Kingdom)
Source:
Annual Congress 2005 - Novel therapies for asthma
Session:
Novel therapies for asthma
Session type:
Poster Discussion
Number:
1733
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. A. Biernacki, S. A. Kharitonov, H. M. Biernacka, P. J. Barnes (London, Gravesend, United Kingdom). Montelukast and frequency of exacerbations of asthma. Eur Respir J 2005; 26: Suppl. 49, 1733
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Could montelukast reduce asthma exacerbations?
Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008
Montelukast in cases of severe asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 407s
Year: 2002
Montelukast reduces viral-induced asthma exacerbations: the PREVIA study
Source: Eur Respir J 2004; 24: Suppl. 48, 212s
Year: 2004
Antibiotics in exacerbations of asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
The effect of bronchiectasis on asthma exacerbations
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Omalizumab reduces asthma exacerbations in children (6–<12 years) with moderate-to-severe allergic (IgE-mediated) asthma irrespective of baseline LABA use
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009
Ceruloplasmine efficacy in patients with asthma exacerbations
Source: Annual Congress 2011 - Novel mechanisms in lung injury
Year: 2011
Montelukast in exercise-induced asthma in children
Source: Eur Respir J 2006; 28: Suppl. 50, 263s
Year: 2006
Perceived bronchodilator efficacy during severe asthma exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 315s
Year: 2006
Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 663s
Year: 2006
Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017
Bronchodilator treatment for asthma and COPD
Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD
Year: 2010
Nebulized therapy in bronchial asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 52s
Year: 2002
Cough in exacerbations of COPD
Source: Annual Congress 2008 - COPD: from bench to bedside
Year: 2008
Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 283s
Year: 2003
Effects of anti-IgE on asthma exacerbations
Source: Eur Respir J 2003; 22: Suppl. 45, 12s
Year: 2003
Increase in α-defensins during rhinovirus-induced experimental asthma exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 154s
Year: 2006
Exacerbations of asthma and treatment
Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept